Oura M - Search Results

1

Serum B-cell maturation antigen could be a simple and accurate biomarker to identify and prognosticate monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Toho M, Ikeda D, Aikawa S, Misono C, Oura M, Fujii F, Sakuma H, Uehara A, Tabata RI, Narita K, Takeuchi M, Watari T, Otsuka Y, Matsue K. Toho M, et al. Among authors: oura m. Haematologica. 2025 Jan 9. doi: 10.3324/haematol.2024.286842. Online ahead of print. Haematologica. 2025. PMID: 39781647 Free article.

2

A brief history of the development of transcranial tissue Doppler ultrasound.

Nicholls JK, Lecchini-Visintini A, Ince J, Pallett E, Minhas JS, Oura M, Chung EML. Nicholls JK, et al. Among authors: oura m. Interface Focus. 2024 Dec 6;14(6):20240031. doi: 10.1098/rsfs.2024.0031. eCollection 2024 Dec 6. Interface Focus. 2024. PMID: 39649445 Free PMC article.

3

Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.

Inoue Y, Tenshin H, Teramachi J, Sumitani R, Oda A, Maeda Y, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Hara T, Endo I, Kagawa K, Ozaki S, Hiasa M, Harada T, Abe M. Inoue Y, et al. Among authors: oura m. Cancer Sci. 2024 Nov 18. doi: 10.1111/cas.16401. Online ahead of print. Cancer Sci. 2024. PMID: 39557586 Free article.

4

Genome-resolved metaproteogenomic and nanosolid characterization of an inactive vent chimney densely colonized by enigmatic DPANN archaea.

Takamiya H, Kouduka M, Kato S, Suga H, Oura M, Yokoyama T, Suzuki M, Mori M, Kanai A, Suzuki Y. Takamiya H, et al. Among authors: oura m. ISME J. 2024 Jan 8;18(1):wrae207. doi: 10.1093/ismejo/wrae207. ISME J. 2024. PMID: 39499858 Free PMC article.

5

Acute myeloid leukemia developed through myeloproliferative features during immunosuppressive therapy for juvenile idiopathic arthritis.

Oura M, Sumitani R, Maeda Y, Yagi H, Takahashi M, Harada T, Fujii S, Miki H, Hori T, Murai J, Kagawa K, Abe M, Nakamura S. Oura M, et al. J Med Invest. 2024;71(3.4):335-339. doi: 10.2152/jmi.71.335. J Med Invest. 2024. PMID: 39462577 Free article.

6

Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma.

Ikeda D, Aikawa S, Misono C, Oura M, Fujii F, Sakuma H, Toho M, Uehara A, Tabata R, Narita K, Takeuchi M, Watari T, Otsuka Y MT, Matsue K. Ikeda D, et al. Among authors: oura m. Blood. 2024 Oct 23:blood.2024026028. doi: 10.1182/blood.2024026028. Online ahead of print. Blood. 2024. PMID: 39441915

7

Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study.

Maeda Y, Takao S, Morita S, Kondo S, Yamashita M, Sumitani R, Oura M, Sogabe K, Takahashi M, Fujii S, Harada T, Miki H, Abe M, Nakamura S. Maeda Y, et al. Among authors: oura m. BMJ Support Palliat Care. 2024 Oct 1:spcare-2024-005070. doi: 10.1136/spcare-2024-005070. Online ahead of print. BMJ Support Palliat Care. 2024. PMID: 39353719

8

Effective Intractable Chylous Ascites Treatment by Lymphangiography with Lipiodol in a Patient with Follicular Lymphoma.

Sumitani R, Higashi K, Oura M, Maeda Y, Yagi H, Sogabe K, Takahashi M, Harada T, Fujii S, Miki H, Abe M, Nakamura S. Sumitani R, et al. Among authors: oura m. Intern Med. 2024 Sep 27. doi: 10.2169/internalmedicine.4175-24. Online ahead of print. Intern Med. 2024. PMID: 39343573 Free article.

9

Analysis of the clinical features and outcomes of relapsed intravascular large B-cell lymphoma: a single center study.

Narita K, Okamoto A, Iba S, Tabata R, Ikeda D, Oura M, Uehara A, Takeuchi M, Takeuchi K, Tomita A, Matsue K. Narita K, et al. Among authors: oura m. Leuk Lymphoma. 2024 Dec;65(13):2052-2055. doi: 10.1080/10428194.2024.2389213. Epub 2024 Sep 3. Leuk Lymphoma. 2024. PMID: 39225391 No abstract available.

10

Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies.

Ikeda D, Isezaki T, Narita K, Yuyama S, Oura M, Uehara A, Tabata R, Takeuchi M, Matsue K. Ikeda D, et al. Among authors: oura m. Cancer Chemother Pharmacol. 2024 Sep;94(3):397-406. doi: 10.1007/s00280-024-04687-z. Epub 2024 Jun 21. Cancer Chemother Pharmacol. 2024. PMID: 38902559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters